1. Home
  2. MC vs PRCT Comparison

MC vs PRCT Comparison

Compare MC & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MC
  • PRCT
  • Stock Information
  • Founded
  • MC 2007
  • PRCT 2009
  • Country
  • MC United States
  • PRCT United States
  • Employees
  • MC N/A
  • PRCT N/A
  • Industry
  • MC Investment Managers
  • PRCT Medical Specialities
  • Sector
  • MC Finance
  • PRCT Health Care
  • Exchange
  • MC Nasdaq
  • PRCT Nasdaq
  • Market Cap
  • MC 4.1B
  • PRCT 3.4B
  • IPO Year
  • MC 2014
  • PRCT 2021
  • Fundamental
  • Price
  • MC $63.48
  • PRCT $76.60
  • Analyst Decision
  • MC Sell
  • PRCT Strong Buy
  • Analyst Count
  • MC 7
  • PRCT 6
  • Target Price
  • MC $56.00
  • PRCT $74.17
  • AVG Volume (30 Days)
  • MC 523.7K
  • PRCT 783.2K
  • Earning Date
  • MC 10-31-2024
  • PRCT 10-30-2024
  • Dividend Yield
  • MC 3.78%
  • PRCT N/A
  • EPS Growth
  • MC N/A
  • PRCT N/A
  • EPS
  • MC 0.19
  • PRCT N/A
  • Revenue
  • MC $969,128,000.00
  • PRCT $176,575,000.00
  • Revenue This Year
  • MC $31.27
  • PRCT $62.29
  • Revenue Next Year
  • MC $25.13
  • PRCT $40.21
  • P/E Ratio
  • MC $334.97
  • PRCT N/A
  • Revenue Growth
  • MC 19.89
  • PRCT 73.74
  • 52 Week Low
  • MC $38.58
  • PRCT $24.83
  • 52 Week High
  • MC $70.00
  • PRCT $85.81
  • Technical
  • Relative Strength Index (RSI)
  • MC 46.68
  • PRCT 58.52
  • Support Level
  • MC $63.82
  • PRCT $73.73
  • Resistance Level
  • MC $65.73
  • PRCT $77.33
  • Average True Range (ATR)
  • MC 1.59
  • PRCT 4.52
  • MACD
  • MC -0.34
  • PRCT -0.08
  • Stochastic Oscillator
  • MC 10.86
  • PRCT 57.50

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System,, image-guided, surgical robotic system for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. The company's assets are based in the United States. Its revenue is generated from sales of the AquaBeam Robotic System and the accompanying single-use disposable handpieces.

Share on Social Networks: